A new study has shown that once-weekly oral bisphosphonate can prevent and improve bone loss in men undergoing androgen deprivation therapy (ADT) for prostate cancer. In a randomized, double-blind ...

Alendronate is superior to alfacalcidol for prevention of glucocorticoid-associated bone loss in patients with ulcerative colitis, report Mitsuyama and colleagues. Bone loss is common in patients ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

Researchers from Penn’s School of Dental Medicine found that training innate immune system may lead to increased bone loss in inflammatory conditions. Credit: Chenyao Liu Researchers from Penn’s ...